Josephin Wagner
About Josephin Wagner
Josephin Wagner is a postdoctoral researcher at the National Institutes of Health, specializing in neuroscience with a focus on genomics and epigenetics. She has extensive academic training and clinical experience in neurosurgery and psychiatry, aiming to return to clinical practice in the United States after her fellowship.
Work at National Institutes of Health
Josephin Wagner has been working as a Postdoctoral Researcher at the National Institute on Alcohol Abuse and Alcoholism (NIAAA) within the National Institutes of Health (NIH) since 2020. In this role, she conducts pre-clinical and translational clinical studies that focus on the genomics and epigenetics associated with the neuropathophysiology and treatment of alcohol-use disorders and stroke. Her work contributes to advancing understanding in these areas and aims to inform future clinical practices.
Education and Expertise
Josephin Wagner has an extensive educational background in medicine and neuroscience. She achieved her Doctor of Medicine (MD) from Charité- University Medicine Berlin, Germany, from 2008 to 2014. She furthered her studies by obtaining a Master of Science (MSc) in Medical Biology from the University of Zurich, Switzerland, between 2015 and 2018. Wagner also completed a postgraduate degree in Addiction Research at the National Institutes of Health from 2020 to 2023. Her specialization in neuroscience emphasizes genomics and epigenetics.
Background in Clinical Practice
Prior to her current role at NIH, Josephin Wagner gained clinical experience as a Resident Doctor in Psychiatry at Clienia-Gruppe in Oetwil am See, Zurich, Switzerland, for two months in 2020. She also served as a Resident Doctor in Neurosurgery at Universitätsspital Zürich from 2017 to 2018. These roles provided her with practical insights into patient care and the clinical aspects of her research focus.
Research Experience
Josephin Wagner has a significant research background, having worked as a Scientific Researcher at the University of Zurich from 2015 to 2017. This position allowed her to engage in various research projects, enhancing her expertise in experimental neuroscience. Her research endeavors have consistently aligned with her focus on genomics and epigenetics, contributing to her current studies at NIH.
Future Aspirations
Josephin Wagner aims to return to clinical practice in the United States after completing her postdoctoral fellowship at NIH. Her goal is to integrate her research findings into clinical settings, particularly in the areas of alcohol-use disorders and stroke treatment, thereby bridging the gap between research and practical applications in medicine.